Jay Galeota is President and Chief Executive Officer of Kallyope and serves on our Board of Directors. With 35 years in the field, Jay is one of the few leaders in biopharma whose depth of experience spans large pharmaceutical companies, specialty generics, new company spin-offs, and biotech startups. Jay is known for his passion for innovation and development of breakthrough products and business opportunities.

Prior to joining Kallyope, Jay was President and CEO of Inheris BioPharma, and before that served as President of G&W Laboratories. Prior to this, Jay spent 28 years at Merck & Co., Inc., where he served in senior leadership positions spanning commercial operations, business development, strategy, and innovation, both globally and in the United States. Jay’s last role at Merck was Chief Strategy & Business Development Officer and President, Emerging Businesses. Previously, he was President of Hospital & Specialty Care, which represented more than $10 billion in worldwide revenues from more than 100 countries. He also served as Senior Vice President of Global Human Health Strategy and Business Development, where he helped establish Merck’s Global Health Innovation Fund and the Innovative Venture Group to incubate businesses that broadened the company’s portfolio and established leadership in key therapeutic areas and markets. Jay was instrumental in bringing Merck into the diabetes market, leading the team that launched Januvia and Janumet, which became the company’s top grossing products. He helped lead the merger of Merck and Schering-Plough in 2009, overseeing the integration of their global pharmaceutical and vaccine businesses. Jay began his career in the commercial organization at Merck, where he held several US and global leadership positions and led numerous brands and key product launches across several therapeutic areas.

In addition to Kallyope, Jay serves on the board of Gandeeva Therapeutics and served as an Independent Director at Melinta Therapeutics (MLNT) and Assertio Therapeutics (ASRT). He is also on the boards of Hackensack Meridian Health System and Harvard Business School’s Healthcare Alumni Association, serving as an officer on both. Jay currently serves as Honorary Commander of the United States Air Force 113th Wing and was a member of the Villanova University Dean’s Advisory Council. Jay is the co-author of several publications in Harvard Business Review and Chief Executive and has been a guest lecturer at the Wharton School of the University of Pennsylvania and Columbia Business School.

Jay earned a B.S. in Biology from Villanova University and is a graduate of Harvard Business School’s Advanced Management Program.